Annual Cash & Cash Equivalents
$467.97 M
+$137.61 M+41.65%
31 December 2023
Summary:
Omnicell annual cash & cash equivalents is currently $467.97 million, with the most recent change of +$137.61 million (+41.65%) on 31 December 2023. During the last 3 years, it has risen by +$118.92 million (+34.07%). OMCL annual cash & cash equivalents is now -3.70% below its all-time high of $485.93 million, reached on 31 December 2020.OMCL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$570.63 M
+$13.85 M+2.49%
30 September 2024
Summary:
Omnicell quarterly cash and cash equivalents is currently $570.63 million, with the most recent change of +$13.85 million (+2.49%) on 30 September 2024. Over the past year, it has increased by +$102.66 million (+21.94%). OMCL quarterly cash and cash equivalents is now -9.30% below its all-time high of $629.17 million, reached on 30 September 2020.OMCL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OMCL Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +21.9% |
| 3 y3 years | +34.1% | +63.5% |
| 5 y5 years | +267.9% | +348.6% |
OMCL Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +41.6% | at high | +132.9% |
| 5 y | 5 years | -3.7% | +267.9% | -9.3% | +448.3% |
| alltime | all time | -3.7% | +4733.9% | -9.3% | >+9999.0% |
Omnicell Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $570.63 M(+2.5%) |
| June 2024 | - | $556.78 M(+8.7%) |
| Mar 2024 | - | $512.36 M(+9.5%) |
| Dec 2023 | $467.97 M(+41.7%) | $467.97 M(+4.7%) |
| Sept 2023 | - | $446.84 M(+11.9%) |
| June 2023 | - | $399.46 M(+17.3%) |
| Mar 2023 | - | $340.41 M(+3.0%) |
| Dec 2022 | $330.36 M(-5.4%) | $330.36 M(+24.0%) |
| Sept 2022 | - | $266.40 M(+8.8%) |
| June 2022 | - | $244.95 M(-7.6%) |
| Mar 2022 | - | $265.01 M(-24.1%) |
| Dec 2021 | $349.05 M(-28.2%) | $349.05 M(-27.5%) |
| Sept 2021 | - | $481.55 M(-21.6%) |
| June 2021 | - | $614.24 M(+12.1%) |
| Mar 2021 | - | $548.05 M(+12.8%) |
| Dec 2020 | $485.93 M(+282.0%) | $485.93 M(-22.8%) |
| Sept 2020 | - | $629.17 M(+371.0%) |
| June 2020 | - | $133.58 M(+28.3%) |
| Mar 2020 | - | $104.08 M(-18.2%) |
| Dec 2019 | $127.21 M(+89.3%) | $127.21 M(-7.3%) |
| Sept 2019 | - | $137.28 M(+56.9%) |
| June 2019 | - | $87.48 M(+13.3%) |
| Mar 2019 | - | $77.24 M(+15.0%) |
| Dec 2018 | $67.19 M(+107.2%) | $67.19 M(+52.1%) |
| Sept 2018 | - | $44.17 M(-4.3%) |
| June 2018 | - | $46.17 M(+5.5%) |
| Mar 2018 | - | $43.77 M(+35.0%) |
| Dec 2017 | $32.42 M(-40.5%) | $32.42 M(+334.3%) |
| Sept 2017 | - | $7.47 M(-72.3%) |
| June 2017 | - | $26.94 M(-41.9%) |
| Mar 2017 | - | $46.35 M(-14.9%) |
| Dec 2016 | $54.49 M(-33.7%) | $54.49 M(+15.2%) |
| Sept 2016 | - | $47.29 M(+15.3%) |
| June 2016 | - | $41.03 M(-23.3%) |
| Mar 2016 | - | $53.49 M(-34.9%) |
| Dec 2015 | $82.22 M(-34.7%) | $82.22 M(+42.3%) |
| Sept 2015 | - | $57.76 M(-34.4%) |
| June 2015 | - | $88.03 M(-36.9%) |
| Mar 2015 | - | $139.55 M(+10.9%) |
| Dec 2014 | $125.89 M(+20.4%) | $125.89 M(+20.8%) |
| Sept 2014 | - | $104.19 M(-17.6%) |
| June 2014 | - | $126.38 M(+17.5%) |
| Mar 2014 | - | $107.56 M(+2.9%) |
| Dec 2013 | $104.53 M(+67.8%) | $104.53 M(-10.0%) |
| Sept 2013 | - | $116.19 M(+33.0%) |
| June 2013 | - | $87.33 M(+25.1%) |
| Mar 2013 | - | $69.82 M(+12.0%) |
| Dec 2012 | $62.31 M | $62.31 M(+13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $54.82 M(+1.4%) |
| June 2012 | - | $54.07 M(-73.2%) |
| Mar 2012 | - | $201.42 M(+5.0%) |
| Dec 2011 | $191.76 M(+9.2%) | $191.76 M(+6.9%) |
| Sept 2011 | - | $179.30 M(-1.1%) |
| June 2011 | - | $181.26 M(+4.4%) |
| Mar 2011 | - | $173.67 M(-1.1%) |
| Dec 2010 | $175.63 M(+3.8%) | $175.63 M(-1.7%) |
| Sept 2010 | - | $178.63 M(-3.5%) |
| June 2010 | - | $185.16 M(+2.5%) |
| Mar 2010 | - | $180.61 M(+6.7%) |
| Dec 2009 | $169.23 M(+40.5%) | $169.23 M(+15.7%) |
| Sept 2009 | - | $146.31 M(+15.7%) |
| June 2009 | - | $126.43 M(+6.4%) |
| Mar 2009 | - | $118.85 M(-1.3%) |
| Dec 2008 | $120.44 M(-29.1%) | $120.44 M(-3.7%) |
| Sept 2008 | - | $125.03 M(+1.8%) |
| June 2008 | - | $122.78 M(-13.9%) |
| Mar 2008 | - | $142.58 M(-16.0%) |
| Dec 2007 | $169.81 M(+179.0%) | $169.81 M(-3.4%) |
| Sept 2007 | - | $175.75 M(+2.1%) |
| June 2007 | - | $172.14 M(+166.2%) |
| Mar 2007 | - | $64.67 M(+6.3%) |
| Dec 2006 | $60.86 M(+106.0%) | $60.86 M(+21.5%) |
| Sept 2006 | - | $50.08 M(+14.4%) |
| June 2006 | - | $43.77 M(+29.3%) |
| Mar 2006 | - | $33.85 M(+14.6%) |
| Dec 2005 | $29.54 M(+51.6%) | $29.54 M(+0.1%) |
| Sept 2005 | - | $29.50 M(+21.6%) |
| June 2005 | - | $24.26 M(+59.1%) |
| Mar 2005 | - | $15.25 M(-21.7%) |
| Dec 2004 | $19.48 M(-20.5%) | $19.48 M(-8.8%) |
| Sept 2004 | - | $21.37 M(+6.0%) |
| June 2004 | - | $20.17 M(-19.9%) |
| Mar 2004 | - | $25.20 M(+2.8%) |
| Dec 2003 | $24.50 M(+14.5%) | $24.50 M(-8.7%) |
| Sept 2003 | - | $26.82 M(+3.0%) |
| June 2003 | - | $26.03 M(+12.9%) |
| Mar 2003 | - | $23.06 M(+7.8%) |
| Dec 2002 | $21.40 M(+26.5%) | $21.40 M(+1.0%) |
| Sept 2002 | - | $21.18 M(+49.7%) |
| June 2002 | - | $14.15 M(+9.1%) |
| Mar 2002 | - | $12.97 M(-23.3%) |
| Dec 2001 | $16.91 M(+74.7%) | $16.91 M(-31.3%) |
| Sept 2001 | - | $24.62 M(+924.9%) |
| June 2001 | - | $2.40 M(+4.0%) |
| Mar 2001 | - | $2.31 M |
| Dec 2000 | $9.68 M | - |
FAQ
- What is Omnicell annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Omnicell?
- What is Omnicell quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Omnicell?
- What is Omnicell quarterly cash and cash equivalents year-on-year change?
What is Omnicell annual cash & cash equivalents?
The current annual cash & cash equivalents of OMCL is $467.97 M
What is the all time high annual cash & cash equivalents for Omnicell?
Omnicell all-time high annual cash & cash equivalents is $485.93 M
What is Omnicell quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OMCL is $570.63 M
What is the all time high quarterly cash and cash equivalents for Omnicell?
Omnicell all-time high quarterly cash and cash equivalents is $629.17 M
What is Omnicell quarterly cash and cash equivalents year-on-year change?
Over the past year, OMCL quarterly cash and cash equivalents has changed by +$102.66 M (+21.94%)